Filing Details
- Accession Number:
- 0001371285-18-000231
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-19 19:11:56
- Reporting Period:
- 2018-11-15
- Accepted Time:
- 2018-11-19 19:11:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1611679 | Darryl Rawlings | C/O Trupanion, Inc. 6100 4Th Avenue South, Suite 200 Seattle WA 98108 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-15 | 181,531 | $0.90 | 1,555,997 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-11-15 | 81,053 | $23.58 | 1,474,944 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-11-15 | 4,000 | $24.18 | 1,470,944 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-11-15 | 181,531 | $0.90 | 181,531 | $0.90 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 181,530 | 2018-12-04 | No | 4 | M | Direct |
Footnotes
- The sale reported was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on August 7, 2018, in order to fund the exercise price and associated taxes on the stock options set to expire if not exercised on, or prior to, December 2018. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.58 to $23.93 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 7, 2017, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. In aggregate, the reporting person's plan is Rule 10b5-1 trading plan is part of a diversification strategy on the part of the reporting person to diversify up to 25% of the reporting person's holdings as of the date of the Company's initial public offering in July 2014 from the inception of the Rule 10b5-1 trading plan through 2025.
- All the shares reported in Column 4 were purchased at the exact price disclosed.
- The option is fully vested.
Billionaire Hedge Funds
